Mie Arakawa

469 total citations
13 papers, 244 citations indexed

About

Mie Arakawa is a scholar working on Epidemiology, Physiology and Hepatology. According to data from OpenAlex, Mie Arakawa has authored 13 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Physiology and 4 papers in Hepatology. Recurrent topics in Mie Arakawa's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Adipose Tissue and Metabolism (3 papers). Mie Arakawa is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Adipose Tissue and Metabolism (3 papers). Mie Arakawa collaborates with scholars based in Japan and United States. Mie Arakawa's co-authors include Masataka Seike, Takayuki Masaki, Hironobu Yoshimatsu, Mizuki Endo, Kazunari Murakami, Koichi Honda, Hirotaka Shibata, Koro Gotoh, Tetsuya Kakuma and Yoko Kudo and has published in prestigious journals such as Scientific Reports, Journal of Nutrition and Medicine.

In The Last Decade

Mie Arakawa

10 papers receiving 242 citations

Peers

Mie Arakawa
Mie Arakawa
Citations per year, relative to Mie Arakawa Mie Arakawa (= 1×) peers Kelly‐Ann Leonard

Countries citing papers authored by Mie Arakawa

Since Specialization
Citations

This map shows the geographic impact of Mie Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mie Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mie Arakawa more than expected).

Fields of papers citing papers by Mie Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mie Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mie Arakawa. The network helps show where Mie Arakawa may publish in the future.

Co-authorship network of co-authors of Mie Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mie Arakawa. A scholar is included among the top collaborators of Mie Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mie Arakawa. Mie Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Endo, Mizuki, Tomoko Saito, Mie Arakawa, et al.. (2023). A case of hepatosplenic cat scratch disease with hemophagocytic lymphohistiocytosis. Clinical Journal of Gastroenterology. 16(6). 871–876.
3.
Fukuda, Masahide, Koshiro Tsutsumi, Kensuke Fukuda, et al.. (2023). Tocilizumab-induced mucosal injury in the terminal ileum mimicking intestinal Behçet’s disease: A case report. Medicine. 102(25). e34118–e34118. 3 indexed citations
4.
Tsutsumi, Koshiro, Masahide Fukuda, Kensuke Fukuda, et al.. (2022). Acute Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis That Responded to Glucocorticoid Therapy. Internal Medicine. 62(10). 1501–1506. 1 indexed citations
5.
Endo, Mizuki, Koichi Honda, Tomoko Saito, et al.. (2021). Maximum Plasma Concentration of Lenvatinib Is Useful for Predicting Thrombocytopenia in Patients Treated for Hepatocellular Carcinoma. World Journal of Oncology. 12(5). 165–172. 4 indexed citations
7.
Gotoh, Koro, Yoko Kudo, Mie Arakawa, et al.. (2020). α‐Tocopherol suppresses hepatic steatosis by increasing CPT‐1 expression in a mouse model of diet‐induced nonalcoholic fatty liver disease. Obesity Science & Practice. 7(1). 91–99. 9 indexed citations
8.
Gotoh, Koro, Mie Arakawa, Mizuki Endo, et al.. (2020). Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid. Scientific Reports. 10(1). 18768–18768. 44 indexed citations
9.
Honda, Koichi, Masataka Seike, Mizuki Endo, et al.. (2017). Usefulness of semiquantitative PCR‐Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b. Hepatology Research. 48(4). 255–263. 2 indexed citations
10.
Honda, Koichi, Masataka Seike, Mizuki Endo, et al.. (2016). Risk factors for deterioration of long-term liver function after radiofrequency ablation therapy. World Journal of Hepatology. 8(13). 597–597. 3 indexed citations
11.
Arakawa, Mie, Koichi Honda, Masataka Seike, et al.. (2015). Focal nodular hyperplasia-like lesion of progressive type in a patient with congenital hepatic fibrosis: a case report. Kanzo. 56(9). 461–468.
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026